Immunology / Inflammatory Bowel Disease
Indication
Crohn's Disease
Assets addressing this indication.
Total attributable cost
$46.6B
$46,100/patient
Drug spend
Not yet sourced
All severities · US
Immunology / Inflammatory Bowel Disease
Indication
Assets addressing this indication.
Total attributable cost
$46.6B
$46,100/patient
Drug spend
Not yet sourced
All severities · US
34 of 34 assets